Please login to the form below
PDL BioPharma
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.
Finalists 2020
trans•PLAN. by Bedrock Healthcare Communications. for Hansa Biopharma. SiGHT. by Bedrock Healthcare Communications.
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
He will join the US clinical-stage biopharma next week. Targacept has found a replacement for ex-CEO J Donald deBethizy, who stepped down in June following a difficult spell for
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic.
Biopharma body welcomes EU-UK free trade agreement docs
The two sides in the UK-EU trade negotiations seem to still be poles apart, but the UK biopharma industry at least is pleased about the UK government’s just-published ... in clinical trials – showed that the government had listened to the biopharma
Biopharma and orphan drugs
Nevertheless, the consensus is that EMA and FDA programmes designed to encourage biopharma to develop medicines for smaller patient populations – primarily the orphan designation – are working. ... While there are differences in the specific
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
HAVAS Just::
HAVAS Just:: is a different kind of healthcare communications agency. Our mission is to create campaigns that make people think....
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
